Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis.
about
Bitter melon: a panacea for inflammation and cancerEffect of Momordica charantia protein on proliferation, apoptosis and the AKT signal transduction pathway in the human endometrial carcinoma Ishikawa H cell line in vitro.[DLys(6)]-luteinizing hormone releasing hormone-curcumin conjugate inhibits pancreatic cancer cell growth in vitro and in vivo.Momordica charantia Extract Induces Apoptosis in Human Cancer Cells through Caspase- and Mitochondria-Dependent Pathways.Kuguaglycoside C, a constituent of Momordica charantia, induces caspase-independent cell death of neuroblastoma cells.Inhibitory effects of crude extracts from some edible Thai plants against replication of hepatitis B virus and human liver cancer cells.Bitter melon reduces head and neck squamous cell carcinoma growth by targeting c-Met signaling.Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approachDevelopment of novel simple sequence repeat markers in bitter gourd (Momordica charantia L.) through enriched genomic libraries and their utilization in analysis of genetic diversity and cross-species transferability.Polyphenol-rich sweet potato greens extract inhibits proliferation and induces apoptosis in prostate cancer cells in vitro and in vivo.Bitter melon extract impairs prostate cancer cell-cycle progression and delays prostatic intraepithelial neoplasia in TRAMP modelA Label-Free Electrochemical Impedance Cytosensor Based on Specific Peptide-Fused Phage Selected from Landscape Phage LibraryA novel angiogenesis inhibitor impairs lovo cell survival via targeting against human VEGFR and its signaling pathway of phosphorylationAntimigratory Effects of the Methanol Extract from Momordica charantia on Human Lung Adenocarcinoma CL1 CellsTargeting AMPK signaling in combating ovarian cancers: opportunities and challenges.Cucurbitane Triterpenoid from Momordica charantia Induces Apoptosis and Autophagy in Breast Cancer Cells, in Part, through Peroxisome Proliferator-Activated Receptor γ Activation.Bitter melon juice activates cellular energy sensor AMP-activated protein kinase causing apoptotic death of human pancreatic carcinoma cells.Overview of Botanical Status in EU, USA, and Thailand.Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth.The genome-wide expression profile of 1,2,3,4,6-penta-O-galloyl-β-D-glucose-treated MDA-MB-231 breast cancer cells: molecular target on cancer metabolism.Bitter melon extracts enhance the activity of chemotherapeutic agents through the modulation of multiple drug resistance.Antitumoral effect of PLK-1-inhibitor BI2536 in combination with cisplatin and docetaxel in squamous cell carcinoma cell lines of the head and neck.Bitter Melon Enhances Natural Killer-Mediated Toxicity against Head and Neck Cancer Cells.Phytochemicals in the Fight Against Cancer.One new 19-nor cucurbitane-type triterpenoid from the stems of Momordica charantia.Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.Small molecules in combination with conventional chemotherapeutic drugs: Light at the end of the tunnel?Methanolic extracts of bitter melon inhibit colon cancer stem cells by affecting energy homeostasis and autophagy.Momordica charantia: a popular health-promoting vegetable with multifunctionality.Nomilin inhibits metastasis via induction of apoptosis and regulates the activation of transcription factors and the cytokine profile in B16F-10 cells.Effects of the Polo-like-kinase-1-inhibitor BI2536 in squamous cell carcinoma cell lines of the head and neck.Awareness and current knowledge of breast cancer.Fighting cancer from different signalling pathways: Effects of the proteasome inhibitor Bortezomib in combination with the polo-like-kinase-1-inhibitor BI2536 in SCCHNBitter melon extract inhibits breast cancer growth in preclinical model by inducing autophagic cell death.P2Y11 impairs cell proliferation by induction of cell cycle arrest and sensitizes endothelial cells to cisplatin-induced cell death.Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade.Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency.Recent Advances in Momordica charantia: Functional Components and Biological Activities.Bitter Melon Prevents the Development of 4-NQO-Induced Oral Squamous Cell Carcinoma in an Immunocompetent Mouse Model by Modulating Immune Signaling.
P2860
Q28817944-9C09D89E-95E8-4D0E-8080-E1C87B870E8BQ33684917-2526C71B-6CB0-4428-8549-86A1B8E230FFQ33724860-48ABC490-F045-4245-8CD7-8BB7C2B48F97Q34034102-3D081296-F0BB-44F6-9D87-B2721FDE2642Q34408500-831F660D-3058-4E5F-8256-33B432AB4A46Q34502260-CA294BBE-8A41-46A0-A636-E235191BFB0FQ35023515-0A85E515-C4B7-4FBC-BCBC-9D22D95B69E6Q35206870-EE7B72CF-BE1A-43DE-86E4-D11D4685E90AQ35266878-B1462224-1977-4E8D-BB0C-106C03238BC0Q35562916-2AA48AB9-907D-45AC-A93A-9F0AAF4D36EAQ35597031-9F6E0203-8D02-4633-AAC3-AEB781DEB797Q35933415-D5F1FB8F-CD5E-4E2D-95A5-5244135CDDADQ36347241-F6309E61-2D94-4DF1-9682-120321668FB8Q36505151-9648217D-4009-47D3-8794-65B61FE04697Q36949580-DC353CC1-BEB7-4D00-919F-72734EBBE82CQ36969586-4A72CDCD-4E5F-4498-A092-A68E22663070Q36971958-2AECF685-0E60-43FB-921F-1D0F952A5F14Q37283479-CEC49E5C-E526-4F4A-A207-4F5BED9B45B7Q37362880-1EB9288D-8510-4E77-AE53-DF3EED041E94Q37461264-D78A9E7F-6A85-4915-B03A-9E65246DFC15Q37610933-091C2696-5031-472F-96A0-915992551810Q38292744-C89FC974-888C-471D-986F-04283F576DA9Q38705138-0D191A97-D9D4-43D1-B13F-FAAF1D02561AQ38726725-5173183D-8995-4DE8-8147-32D4E04C645AQ38821885-0939BA9C-2540-4CCA-846B-B4407F670367Q38907047-814A0517-EF9E-4080-943D-DFCBDE11F7E8Q39171958-FD81A43D-60BB-440F-8CA7-4D632F1024A1Q39242775-11DB6FCD-6EF5-4198-BE8D-7D8347DC9689Q39243695-87CE1918-5908-4015-BF00-66FD502B1BB6Q39285044-ED60D41E-8AAC-43DC-9941-F8C0ABCBBC7EQ39526145-8C04A3A1-ACBF-4FE7-BB72-7BA012640C7BQ42036348-65EE79E9-E38F-4472-8D1E-2E297FA1294CQ42176053-33EE4D20-9570-4C93-8D47-2F62235A9B02Q42355050-3462BDC6-235C-499E-A7E9-0DE8DCAE0BE2Q42371624-7BD61043-DC29-4900-A78F-CC9876D080D7Q42742419-47E906B3-463A-4924-A870-0E9EE1FE1343Q46799064-B140C640-CE08-4080-B164-A18A2B2F4F90Q47132559-05873275-A86C-48B3-BF0C-FF40E47CCE06Q47356636-69302935-BA67-4DEC-809B-E5346754842AQ47736009-DC8EAD5F-93DD-41E5-B3DC-FDA52E67F4F9
P2860
Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Bitter melon (Momordica charan ...... genes and promotes apoptosis.
@ast
Bitter melon (Momordica charan ...... genes and promotes apoptosis.
@en
Bitter melon
@nl
type
label
Bitter melon (Momordica charan ...... genes and promotes apoptosis.
@ast
Bitter melon (Momordica charan ...... genes and promotes apoptosis.
@en
Bitter melon
@nl
prefLabel
Bitter melon (Momordica charan ...... genes and promotes apoptosis.
@ast
Bitter melon (Momordica charan ...... genes and promotes apoptosis.
@en
Bitter melon
@nl
P2093
P1433
P1476
Bitter melon (Momordica charan ...... genes and promotes apoptosis.
@en
P2093
Amit Raychoudhuri
Pratibha Nerurkar
Robert Steele
P304
P356
10.1158/0008-5472.CAN-09-3438
P407
P50
P577
2010-02-23T00:00:00Z